CSPC Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: HK1093012172
HKD
9.71
0.89 (10.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Wuxi Biologics (Cayman), Inc.
3SBio, Inc.
Alphamab Oncology
CSPC Pharmaceutical Group Ltd.
Sirnaomics Ltd.
Zai Lab Ltd.
AIM Vaccine Co., Ltd.
Ascentage Pharma Group International Co., Ltd.
Laekna, Inc.
Beijing Lüzhu Biotechnology Co., Ltd.
Genscript Biotech Corp.

Why is CSPC Pharmaceutical Group Ltd. ?

1
Flat results in Jun 25
  • OPERATING CASH FLOW(Y) Lowest at HKD 11,933.18 MM
  • ROCE(HY) Lowest at 11.25%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.45 times
2
With ROE of 6.15%, it has a Very Expensive valuation with a 3.39 Price to Book Value
  • Over the past year, while the stock has generated a return of 75.59%, its profits have risen by 25.8% ; the PEG ratio of the company is 2.4
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CSPC Pharmaceutical Group Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
CSPC Pharmaceutical Group Ltd.
-100.0%
0.67
57.42%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.96%
EBIT Growth (5y)
19.40%
EBIT to Interest (avg)
29.07
Debt to EBITDA (avg)
2.63
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.37
Tax Ratio
19.81%
Dividend Payout Ratio
65.03%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
18.91%
ROE (avg)
14.36%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
55
Industry P/E
Price to Book Value
3.39
EV to EBIT
39.55
EV to EBITDA
32.74
EV to Capital Employed
4.15
EV to Sales
8.73
PEG Ratio
2.40
Dividend Yield
0.02%
ROCE (Latest)
10.48%
ROE (Latest)
6.15%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DIVIDEND PAYOUT RATIO(Y)

Highest at 58.48%

-8What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at HKD 11,933.18 MM

ROCE(HY)

Lowest at 11.25%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.45 times

RAW MATERIAL COST(Y)

Grown by 6.18% (YoY

Here's what is working for CSPC Pharmaceutical Group Ltd.

Dividend Payout Ratio
Highest at 58.48% and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for CSPC Pharmaceutical Group Ltd.

Operating Cash Flow
Lowest at HKD 11,933.18 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Debtors Turnover Ratio
Lowest at 2.45 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 6.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at HKD 0.13 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income